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ABSTRACT 
Objective
To evaluate the experience of, and services to, patients from rural and regional Australia referred to a large urban 
tertiary referral hospital for allogeneic haematopoietic cell transplantation (allo‑HCT) and to compare their quality of 
life with similar populations.
Design and setting
A cross‑sectional survey of allo‑HCT recipients referred from the Calvary Mater Newcastle to Westmead Hospital, 
Sydney, NSW. 
Subjects
Thirty‑seven of forty adult survivors of allo‑HCT (92.5%) who underwent transplant between 1999 and 2008 and 
were at least three months post transplant.
Intervention
All subjects completed a validated measure of quality‑of‑life (QoL) in bone marrow transplant recipients (FACT‑BMT 
Version 4) and the Regional/Rural BMT Needs Assessment Survey. 
Results
Most	patients	(79%)	were	between	one	and	five	years	post	transplant.	Almost	all	reported	having	been	sufficiently	
prepared for transplant and received most information and support from the Nurse Coordinator. Despite the fact 
that	89%	of	patients	reported	significant	adverse	effects	of	allo‑HCT,	>60%	still	reported	an	acceptable	quality	of	
life.	Importantly,	however,	about	a	third	of	patients	experienced	financial	difficulties	associated	with	transplantation	
and felt pressure to return to work. 
Conclusion
Patients referred for allo‑HCT should be advised about the arduousness of transplant but also reassured that most 
survivors	will	experience	acceptable	levels	of	functioning	and	QoL	one	to	two	years	after	transplant.	With	sufficient	
local support and with appropriate nursing care and coordination the experiences of regional/rural patients is 
comparable with other allo‑HCT patient populations. Further investigation into vocational rehabilitation is warranted 
due	to	the	significant	financial	and	occupational	pressures	reported	by	survivors	of	allo‑HCT.	
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INTRODUCTION
Allogeneic hematopoietic cell transplantation (Allo‑HCT or BMT) is a complex, demanding treatment with a 
high treatment‑related mortality and morbidity, requiring a prolonged hospital stay and an extended recovery 
period (Heinonen et al 2003). Approximately 35‑80% of transplant recipients will become long‑term survivors 
who may experience late effects capable of impairing quality of life (QoL) (Pidala et al 2009; Syrjala et al 
2004; Socie et al 1999; Curtis et al 1997). 
Allogeneic transplant is performed only in major urban tertiary referral centres. BMT may therefore impose 
additional strains for the 26% of Australians living in rural or regional areas, such as travel, isolation, separation 
from	social	support,	family	upheaval,	and	financial	strain	due	to	distance	from	the	treatment	centre	(Underhill	
et	al	2006;	Burkitt	2003;	McGrath	et	al	1999).	These	people	may	also	experience	difficulties	arising	from	
limited access to specialist services and fragmentation of healthcare between regional and metropolitan 
services (Drury and Inma 2009; Baldwin et al 2008; Hubbard et al 2006; Martin‑Macdonald et al 2003; 
Fitzgerald et al 2001; Davis et al 1998). These challenges may increase psychological and emotional distress 
following BMT and impair treatment compliance, QoL and even the likelihood of survival (Hubbard et al 2006; 
Grulke et al 2005; Lock et al 2005). 
In	recent	years,	Cancer	Care	Coordinators	have	been	employed	in	key	regional	centres	to	address	the	specific	
needs of cancer patients living in rural and regional areas (Drury and Inma 2009). While there is some 
literature on the experience of Australian women with chronic illness and cancer living in rural and remote 
areas, there is no published data on the QoL, experiences and health service utilisation of patients from 
rural/regional areas of Australia referred for BMT (Drury and Chutarat 2010; Baldwin et al 2008; Clavarino et 
al 2002; Fitzgerald et al 2001; McGrath et al 1999). This is an important omission as one would anticipate 
from international literature that patients from rural and regional Australia would have a poorer experience 
of BMT and consequently have a reduced QoL. This study therefore aimed to evaluate the experiences of 
and services to patients from regional areas undergoing BMT at a large metropolitan centre in NSW, and to 
compare the QoL in this sample with similar patients based on previous studies.
PATIENTS AND METHODS
Background to the service
Each year, 10‑15 patients from the Hunter New England area are referred from the Calvary Mater Hospital, 
Newcastle (CMN) to Westmead Hospital, Sydney, for allo‑HCT. The Hunter New England area is located approx 
150km north of Sydney, covers an area of 130,000km2, and has a population of 840,000. This represents 
12% of the total population of New South Wales, the most populous state in Australia (HNE Health District 
2010). Most BMT recipients spend four to six weeks as an inpatient in the transplant ward. Following discharge 
from hospital, all allo‑BMT recipients attend a weekly outpatient clinic at Westmead Hospital for up to three 
months. To attend, patients from rural and regional areas must initially remain in Sydney. Most stay in local 
accommodation provided by the Leukaemia Foundation (LF). Later, patients must commute weekly to Sydney 
from home, which often entails a round trip of 400‑500km. Once medically stable, the care of BMT recipients 
from the Newcastle and Hunter region is transferred to a monthly clinic run by a BMT CNC at the CMN and 
staffed by BMT physicians from Westmead Hospital.
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Patients
Patients	eligible	for	this	study	were	adult	(age	>	15	years)	survivors	of	allo‑BMT	from	a	regional	or	rural	area	
referred to Westmead Hospital from the Haematology Department at CMN who underwent transplant at 
Westmead Hospital between 1999 and 2008, and were at least three months (range 3‑96 months, mean 30 
months) post‑transplant at the time of recruitment. Eligible patients were sent a letter describing the study, 
copies of the questionnaires and a stamped self‑addressed envelope. Follow‑up phone calls were made to 
non‑responders after two and four weeks. Participants were asked to complete the Functional Assessment 
of Cancer Therapy – Bone Marrow Transplant (FACT‑BMT Version 4) and the Regional/Rural BMT Needs 
Assessment Survey. 
Assessment
The FACT‑BMT is a validated questionnaire for measuring quality of life in BMT recipients. (McQuellon et al, 
1997) It takes 10‑20 minutes to complete and combines two instruments, the FACT‑G and a BMT subscale. 
The FACT‑G is a 28‑item self‑report instrument that measures QoL in cancer patients (Cella et al 1993). It 
consists	of	five	subscales	measuring	physical,	functional,	social	and	emotional	well‑being	and	satisfaction	with	
the doctor/patient relationship. The BMT subscale includes 12 items designed to test QoL in BMT patients. 
The FACT‑BMT plus the BMT subscale provides an overall quality of life score. Patients rated themselves over 
the past seven days using 5‑step Likert scales. Responses were used to calculate overall quality of life and 
subscale wellbeing scores. 
The Regional/Rural BMT Needs Assessment Survey 
was developed following a review of relevant literature 
and discussions with patients attending BMT long‑term 
follow‑up clinics. It consists of 64 questions grouped into 
four sections covering personal and transplant details, 
medical complications, information and preparation for 
transplant, support and return to work. The questionnaire 
uses tick box responses, short answer and Likert scales 
and takes about 25 minutes to complete. It was piloted in 
phone interviews with four current patients. 
Descriptive statistics were compiled for all items on the 
Regional/Rural BMT Needs Assessment Survey and 
summary scores were calculated for the FACT‑BMT. The 
‘relationship with doctor’ sub‑score was not used as 
participants had multiple clinicians involved in their care. 
QoL scores were extracted from other published reports 
for comparison. The ‘relationship with doctor’ score was 
removed. The study was approved as a quality improvement 
project by the Hunter New England Research Ethics Unit.
RESULTS
Completed questionnaires were received from 37 eligible 
participants (92.5% response rate). The study population 
was balanced in terms of gender and marital status 
(table 1). The majority of participants (78%) were 
Table 1: Participant characteristics (N=37)
Average age (years) 41.8 (range 20‑61)
Gender
Male 21 (57%)
Female 16 (43%)
Family circumstances
Single 14 (38%)
Married/De facto 23 (62%)
Children 24 (65%)
No children 13 (35%)
Employed pre‑BMT
Yes 29 (78%)
No 8 (22%)
Donor
Unrelated Cord blood 1 (3%)
Related 23 (62%)
Adult Unrelated 13 (35%)
Conditioning
Myeloablative 34 (92%)
Reduced intensity 2 (5%)
Not known 1 (3%)
Time since transplant
<1 yr 6 (16%)
1‑5 yr 24 (65%)
>5	yr 5 (14%)
Not known 2 (5%)
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employed prior to transplant and were surveyed 
between	 one	 and	 five	 years	 post	 transplant.	 Of	
those transplant survivors who returned surveys, 
30 (82%) had undergone transplant as treatment 
for acute leukaemia, while the remainder had been 
transplanted for other conditions including aplastic 
anaemia, lymphoma and chronic leukaemia. The 
distribution of donor and transplant type were typical 
for this patient population. Participants reported 
receiving information about BMT mainly from 
clinicians and from resources and events designed 
specifically	for	them	(table	2).	Most	(78%)	reported	
feeling prepared for the transplant by the information 
received beforehand, and most also reported feeling 
physically (78%) and emotionally prepared (62%) 
for transplant at the time of admission with very 
few reporting not feeling either physically (8%) or 
emotionally (3%) well‑prepared for transplant. This 
finding	 was	 supported	 by	 concordance	 between	
expectations of the BMT experience and reports of 
what it was actually like (table 3). 
Most	 participants	 (89%)	 experienced	 significant	
adverse effects of allo‑HSCT with 27% requiring 
readmission to hospital and 15% admission to 
Intensive Care. The most frequently reported 
acute complications of transplant were acute 
graft‑versus‑host disease (GVHD), nausea, vomiting, diarrhoea, mucositis, bacterial infection (central venous 
line infection and pneumonia) and cytomegalovirus (CMV) reactivation. Many (39%) also reported chronic 
GVHD.
Table 2: Sources of information about BMT
Main information sources before admission
BMT coordinator (CMN) 30 (81%)
Transplant physician (Westmead) 24 (65%)
BMT coordinator (Westmead) 22 (59%)
Haematologist (CMN) 22 (59%)
BMT patient education day (Westmead) 19 (51%)
Haematology nurses (CMN) 19 (51%)
Leukaemia Foundation 13 (35%)
Internet 9 (24%)
Other transplant recipients 8 (22%)
NSW BMT Network 3 (8%)
Other sources 1 (3%)
Received BMT Network Booklet
Yes 29 (78%)
No 8 (22%)
Read some or all of booklet (n= 29)
Yes 26 (90%)
No 3 (8%)
Understood most or all of what they read (n=26)
Yes 24 (92%)
No 2 (8%)
Satisfaction with BMT patient education day (n=19)
A	little	or	somewhat	satisfied 4 (21%)
Quite	or	very	satisfied 14 (74%)
Felt prepared for transplant with the information
A little or somewhat 7 (19%)
Quite or very 29 (78%)
Table 3: Expectations and experience of BMT
A terrible ordeal Very difficult Somewhat difficult Not very difficult
Expectations of BMT 5 (14%) 13 (35%) 15 (41%) 3 (8%)
Assessment of actual experience 3 (8%) 10 (27%) 18 (49%) 5 (14%)
Spouses (22; 59%) and parents (12; 32%) were the main sources of support during BMT. Extended family 
(26; 70%), friends (27; 73%) and work colleagues (11; 30%) also provided support in Newcastle during the 
transplant period. Overall, reported perceptions of support suggest that – despite a degree of loneliness – 
the participants’ needs were met most of the time, and that effective support was provided during and after 
BMT by both lay and professional carers (table 4). 
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Of the 29 respondents who were employed before transplant (table 5), 11 (38%) reported feeling some 
pressure to return to work while preparing for and recovering from the transplant. At the time of the survey, 
two thirds (19/29, 66%) had returned to work after a 
median lapse of seven months (range 1 to 18 months). 
One third (10/29, 34%) had not yet returned to work, 
and all but one planned to do so. Of the 19 who had 
returned to work, most (13, 68%) reported some 
degree	 of	 difficulty	 and	 eight	 changed	 the	 nature	
of the work by reducing work hours or by shifting to 
casual or seasonal employment.
Patients main source of income were welfare 
payments (49%), spouse’s income (41%), personal 
savings (24%), insurance (14%) and superannuation 
(14%). Disturbingly, a third of respondents (13; 
35%)	 reported	 having	 insufficient	 finances	 during	
the transplant. The majority of respondents relied 
primarily on private transport whilst undergoing BMT 
(29;	78%),	and	afterwards	while	travelling	between	Newcastle	and	Sydney	(27;	73%),	although	a	significant	
number used transport provided by the LF (13; 35%). More than three quarters of respondents (77%) relied 
on	accommodation	provided	by	the	LF,	and	were	overwhelmingly	satisfied	with	the	accommodation	in	Sydney.	
A	significant	proportion	of	respondents	used	other	services	provided	by	the	Foundation,	including	educational	
resources (32%) and seminars (19%). The majority (62%) made use of the services of the BMT co‑ordinator 
in Newcastle before transplant, as well as other medical and allied health services, including social workers 
(30%), clinical psychologists (27%), dieticians (27%) and psychiatrists (14%). There was little evidence of 
unmet needs for medical, nursing, allied health, pastoral care or support services in Newcastle pre‑BMT.
Most patients reported an acceptable quality of life with the FACT‑BMT scores in the study population being 
comparable to those from similar studies done internationally (table 6).
Table 4: Perceptions of support
 Not at all Some of the time
About half 
of the time
Most of the 
time
All of the 
time
Felt that needs were met 0 (0%) 0 (0%) 2 (5%) 11 (30%) 24 (65%)
Felt alone 12 (32%) 17 (46%) 5 (14%) 1 (3%) 2 (5%)
Felt supported by staff 0 (0%) 3 (8%) 2 (5%) 8 (22%) 24 (65%)
Felt supported by carer 1 (3%) 1 (3%) 0 (0%) 4 (11%) 29 (78%)
Felt supported post‑BMT by Westmead staff 0 (0%) 3 (8%) 0 (0%) 16 (43%) 17 (46%)
Felt supported post BMT by CMN staff 1 (3%) 2 (5%) 1 (3%) 7 (19%) 24 (65%)
Table 5: Employment
Employment pre‑transplant (n=29)
Full time 17 (59%)
Part time 7 (24%)
Casual 3 (10%)
Unknown 2 (7%)
Yes No
Returned to work 
post‑transplant 19 (66%) 10 (34%)
Felt pressure to return to 
work 11 (38%) 18 (62%)
Difficulty	returning	to	work 13 (68%) 6 (32%)
Reduced or changed 
employment 8 (42%) 11 (58%)
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Table 6: Quality of Life scores compared with other studies of BMT patients
Study Participants Location Physical wellbeing
Social 
wellbeing
Emotional 
wellbeing
Functional 
wellbeing FACT‑G
BMT 
subscale*
FACT‑ 
BMT
McQuellon 
et al 
(1998)
45 patients 
12 months 
post‑BMT
Salem NC, 
USA 22.6 23.2 16.8 19.5 82.1 33.6 115.7
Kopp et al 
(1998)
41 patients 
12 months 
post‑BMT
Austria 23.37 20.63 19.63 21.29 82.22 36.61 118.83
Heinonen 
et al 
(2001)
91 patients 
>	12	months	
post BMT
Finland 23.97 21.6 16.5 19.63 81.7 37.37 119.07
This study 
(2008)
41 patients, 
most	>12	
months 
post‑BMT
Newcastle, 
Australia 22.29 22.60 16.25 20.55 81.69 35.58 117.27
*12 Items (McQuellon 1997)
DISCUSSION
Cancer patients need long‑term follow‑up to ascertain their long‑term prognosis and ongoing needs, and to 
assess the adequacy of existing services and interventions. To date, there has been no data on long‑term 
follow up for patients from rural and regional areas of Australia referred for BMT. The instrument developed 
and tested in this study – the Regional/Rural BMT Needs Assessment Survey ‑ can be used in combination 
with validated QoL instruments for this purpose. 
While	this	study	makes	a	significant	contribution	to	the	literature	on	patient	experiences	of	transplantation,	
care must be taken in generalising the results to other populations given the small sample size, the variable 
length of survival post‑transplant and the recruitment of participants from a single geographical region and 
haematology/transplant service. 
This	study	demonstrates	that	the	majority	of	transplant	recipients	experience	significant	short‑term	effects	of	
BMT, but most go on to report an acceptable level of functional and social well‑being. This is consistent with 
longitudinal studies of QoL following BMT, which demonstrate early moderate reductions in QoL that largely 
return	to	pre‑transplant	levels	within	three	to	12	months	of	transplant,	with	the	majority	(>60%)	of	patients	
who survive more than a year reporting good to excellent QoL (Pidala et al 2009; McQuellon et al 1998; 
Kopp et al 1998). It is also consistent with both longitudinal studies of BMT survivors and cross‑sectional 
studies which suggest only modest reductions in the QoL of BMT recipients compared to healthy controls or 
population normative data. (Pidala et al 2009; McQuellon et al 1998; Sutherland et al 1997) Sutherland et al, 
found that allogeneic BMT recipients were indistinguishable from the ‘normal’ population in terms of physical 
functioning, emotional role functioning, bodily pain and general health three years after BMT. Other studies 
have found long‑term allo‑BMT survivors generally report good functional wellbeing relative to population 
norms while continuing to be troubled by fatigue, insomnia, lethargy and sexual dysfunction (Andrykowski et 
al 1997; Sutherland et al 1997; Zittoun et al 1997; Bush et al 1995; Schmidt et al 1993).
Given that other studies have reported reduced QoL in patients with cancer living in rural/regional areas, the 
fact that participants in this study reported reasonable QoL suggests the support provided to patients in this 
sample compensated for any disadvantage resulting from living a long distance from the transplant centre. 
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Due to the small sample size it was not possible to test whether transplant‑related complications were 
associated with a lower QoL. Notably, however, despite the fact many respondents experienced some degree 
of acute (79%) and chronic (39%) GvHD, the majority still reported an acceptable QoL. 
Most	participants	felt	sufficiently	informed	about	the	potential	complications	of	allo‑HSCT,	although	imperfect	
levels of physical (78%) and emotional (63%) preparedness is a reminder that no amount of information can 
fully prepare patients for the full impact of BMT. The results also suggest that, notwithstanding the increasing 
popularity of the internet, events and resources tailored for this patient population, particularly, discussion with 
health professionals responsible for the care of patients referred for transplant, provide the most important 
and effective means of communicating information about BMT. This is consistent with other evidence that 
involvement of cancer nurse coordinators may improve the experience of illness and health care delivery of 
cancer patients in rural/remote settings (Drury and Inma 2010). 
About	a	third	of	the	participants	in	this	study	experienced	financial	pressures	associated	with	transplantation	
and reported feeling pressure to return to work. This is consistent with other evidence that, while many BMT 
recipients	are	able	to	return	to	work	post‑transplant,	many	have	difficulty	doing	so	and	may	benefit	from	some	
form of occupational/vocational rehabilitation (Friedrichs et al 2010; Heinonen et al 2001). Since rural/
regional patients are likely to be disadvantaged when it comes to accessing such services, it is reasonable 
to	infer	that	many	may	be	returning	to	work	prior	to	full	recovery	due	to	financial	pressures.	
While	this	study	provides	some	insights	into	the	significance	of	occupational	pressures	for	survivors	of	BMT,	
further research is needed to establish the degree to which such concerns are shared by other populations 
and to establish whether pre and post‑transplant interventions, including education, counselling and support 
services	may	assist	patients	 return	 to	work	and	help	 them	cope	with	 the	financial	and	social	 impacts	of	
transplantation. Likewise, while this study suggests that the involvement of a clinical nurse coordinator may 
assist BMT recipients cope with the broad impacts of transplant, further research involving different regions 
and health services should be conducted to establish whether nurse coordinators may have a more extensive 
role to play in the management of BMT recipients and to ascertain the optimal model of nursing and medical 
care for BMT patients referred from different rural and regional areas. 
CONCLUSIONS
Patients should be advised that BMT is an arduous treatment associated with serious risks and complications 
and that most BMT recipients will experience short and long‑term consequences of transplant that may 
compromise	QoL	and	conflict	with	expectations	of	recovery.	While	advice	to	potential	BMT	recipients	should	
be	tailored	to	specific	circumstances,	patients	can	be	advised	that	approximately	25%	of	BMT	recipients	will	
have ongoing medical complications. These complications may impair QoL and life‑satisfaction and most 
survivors will experience some symptoms, such as fatigue (Jacobs et al 2007; Lee et al 2001; McQuellon et al 
1998).	They	can	also	be	reassured,	most	BMT	recipients	(>60‑70%)	return	to	acceptable	levels	of	functioning	
within one to two years of transplant and experience a good QoL. 
Whilst	BMT	recipients	receive	a	lot	of	information	about	BMT	from	many	different	sources,	patients	may	benefit	
from additional psychosocial and emotional support prior to transplant and from practical assistance with, 
for	example,	the	financial	costs	associated	with	transplant,	and	vocational	rehabilitation,	to	assist	patients	
in returning to work when ready. 
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The experience of patients from rural/regional areas appears no worse than that reported in similar populations. 
This suggests that any adverse impact of distance on rural/regional patient’s experience of BMT may be 
ameliorated by the supportive care provided before and after transplant by a clinical nurse coordinator, 
combined with support from the LF and social networks. 
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